BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26681225)

  • 1. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
    Yang Q; Zhang C; Huang B; Li H; Zhang R; Huang Y; Wang J
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of microRNA-100 in patients with bladder cancer.
    Cao YH; Zhang HH; Xu HF; Duan YJ; Li Q; Huang B
    Genet Mol Res; 2015 Dec; 14(4):15948-54. PubMed ID: 26662386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
    Zhang HP; Sun FB; Li SJ
    Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study.
    Shi H; Han J; Yue S; Zhang T; Zhu W; Zhang D
    Biomed Pharmacother; 2015 Apr; 71():210-5. PubMed ID: 25960238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
    Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
    Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
    Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of microRNA-93 downregulation in human colon cancer.
    Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis.
    Li BS; Liu H; Yang WL
    Genet Mol Res; 2015 Dec; 14(4):16372-8. PubMed ID: 26662432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
    Liu L; Qu W; Zhong Z
    Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
    Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
    Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-218 tissue expression level is associated with aggressive progression of gastric cancer.
    Wang XX; Ge SJ; Wang XL; Jiang LX; Sheng MF; Ma JJ
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
    Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-153 expression and prognosis in non-small cell lung cancer.
    Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW
    Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between microRNA-421 expression level and prognosis of gastric cancer.
    Liu H; Gao Y; Song D; Liu T; Feng Y
    Int J Clin Exp Pathol; 2015; 8(11):15128-32. PubMed ID: 26823855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.
    Liu K; Li G; Fan C; Diao Y; Wu B; Li J
    J Int Med Res; 2012; 40(2):467-74. PubMed ID: 22613407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.